Marie Marotel
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
TLR9 Downregulation in Breast Cancer: Its Role in Tumor Immunity, Inflammatory Response, and Cellular Senescence.
Journal: Journal of innate immunity
Published: September 12, 2024
Tumor-induced natural killer cell dysfunction is a rapid and reversible process uncoupled from the expression of immune checkpoints.
Journal: Science advances
Published: August 28, 2024
Combinatorial Expression of NK Cell Receptors Governs Cell Subset Reactivity and Effector Functions but Not Tumor Specificity.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 10, 2021
Styk1 is specifically expressed in NK1.1+ lymphocytes including NK, γδ T, and iNKT cells in mice, but is dispensable for their ontogeny and function.
Journal: European journal of immunology
Published: November 27, 2018
Styk1 expression is a hallmark of murine NK cells and other NK1.1+ subsets but is dispensable for NK-cell development and effector functions.
Journal: European journal of immunology
Published: May 28, 2018
Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1β.
Journal: PLoS pathogens
Published: January 12, 2018
Hepatitis B Virus Blocks the CRE/CREB Complex and Prevents TLR9 Transcription and Function in Human B Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 13, 2017
Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic Lymphohistiocytosis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: November 27, 2017
T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1.
Journal: European journal of immunology
Published: September 18, 2017
Regulation of mTOR, Metabolic Fitness, and Effector Functions by Cytokines in Natural Killer Cells.
Journal: Cancers
Published: August 31, 2017
Last Updated: 09/26/2026